Total reported value
$17.5B
Reporting period: 2026-03-31 · Number of holdings: 172
FARALLON CAPITAL MANAGEMENT LLC disclosed 172 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $17.5B and a quarterly turnover rate of 200.0%.
New buy 78462F953
New buy RVMD
New buy AMZN
New buy MSFT
New buy AON
New buy BBIO
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&p 500 ETF Tr | ETF-Large Cap & Growth | 8.53% | +8.53% | NEW | |
| 2 | RVMD | Revolution Medicines INC | Stock-Healthcare | 7.54% | +7.54% | NEW | |
| 3 | AMZN | Amazon.com INC | Stock-Consumer Disc | 5.01% | +5.01% | NEW | |
| 4 | MSFT | Microsoft CORP | Stock-Tech | 4.95% | +4.95% | NEW | |
| 5 | AON | Aon plc | Stock-Financials | 4.62% | +4.62% | NEW | |
| 6 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 3.96% | +3.96% | NEW | |
| 7 | ✓ | Invesco Exchange Traded Fd T | Stock-Other | 3.94% | +3.94% | NEW | |
| 8 | PTGX | Protagonist Therapeutics INC | Stock-Other | 3.81% | +3.81% | NEW | |
| 9 | NTRA | Natera INC | Stock-Healthcare | 3.66% | +3.66% | NEW | |
| 10 | EXEL | Exelixis INC | Stock-Healthcare | 3.21% | +3.21% | NEW | |
| 11 | AVGO | Broadcom INC | Stock-Tech | 3.14% | +3.14% | NEW | |
| 12 | UNH | Unitedhealth Group INC | Stock-Healthcare | 2.81% | +2.81% | NEW | |
| 13 | SNPS | Synopsys INC | Stock-Tech | 2.74% | +2.74% | NEW | |
| 14 | BSX | Boston Scientific CORP | Stock-Healthcare | 2.67% | +2.67% | NEW | |
| 15 | TMO | Thermo Fisher Scientific INC | Stock-Healthcare | 2.47% | +2.47% | NEW | |
| 16 | KKR | Kkr & Co INC | Stock-Financials | 2.46% | +2.46% | NEW | |
| 17 | LNTH | Lantheus Holdings INC | Stock-Healthcare | 2.41% | +2.41% | NEW | |
| 18 | WAB | Wabtec CORP | Stock-Industrials | 2.29% | +2.29% | NEW | |
| 19 | SCHW | Schwab (charles) CORP | Stock-Financials | 2.12% | +2.12% | NEW | |
| 20 | LQDA | Liquidia CORP | Stock-Other | 1.86% | +1.86% | NEW | |
| 21 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.73% | +1.73% | NEW | |
| 22 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 1.63% | +1.63% | NEW | |
| 23 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.53% | +1.53% | NEW | |
| 24 | V | Visa Inc-class A Shares | Stock-Financials | 1.45% | +1.45% | NEW | |
| 25 | ARMK | Aramark | Stock-Industrials | 1.42% | +1.42% | NEW | |
| 26 | BEAM | Beam Therapeutics INC | Stock-Other | 1.38% | +1.38% | NEW | |
| 27 | DIS | Walt Disney Co/the | Stock-Comm Services | 1.32% | +1.32% | NEW | |
| 28 | MA | Mastercard INC - A | Stock-Financials | 1.24% | +1.24% | NEW | |
| 29 | MCK | Mckesson CORP | Stock-Healthcare | 1.16% | +1.16% | NEW | |
| 30 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 1.10% | +1.10% | NEW | |
| 31 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 1.09% | +1.09% | NEW | |
| 32 | TNGX | Tango Therapeutics INC | Stock-Other | 1.08% | +1.08% | NEW | |
| 33 | GRAL | Grail INC | Stock-Healthcare | 0.96% | +0.96% | NEW | |
| 34 | TYRA | Tyra Biosciences INC | Stock-Other | 0.78% | +0.78% | NEW | |
| 35 | THC | Tenet Healthcare CORP | Stock-Healthcare | 0.49% | +0.49% | NEW | |
| 36 | CAH | Cardinal Health INC | Stock-Healthcare | 0.44% | +0.44% | NEW | |
| 37 | PCVX | Vaxcyte INC | Stock-Other | 0.42% | +0.42% | NEW | |
| 38 | DNTH | Dianthus Therapeutics INC | Stock-Other | 0.40% | +0.40% | NEW | |
| 39 | BTSG | Brightspring Health Services | Stock-Other | 0.39% | +0.39% | NEW | |
| 40 | TWST | Twist Bioscience CORP | Stock-Other | 0.39% | +0.39% | NEW | |
| 41 | BIDU | Baidu INC - Spon Adr | Stock-Comm Services | 0.28% | +0.28% | NEW | |
| 42 | CGON | Cg Oncology INC | Stock-Other | 0.26% | +0.26% | NEW | |
| 43 | AZN | AstraZeneca PLC | Stock-Healthcare | 0.25% | +0.25% | NEW | |
| 44 | VNET 2 10-01-27 | Vnet Group INC | Stock-Other | 0.25% | +0.25% | NEW | |
| 45 | MRK | Merck & Co. INC. | Stock-Healthcare | 0.25% | +0.25% | NEW | |
| 46 | ACHC | Acadia Healthcare Co INC | Stock-Other | 0.23% | +0.23% | NEW | |
| 47 | WELL | Welltower INC | Stock-Real Estate | 0.23% | +0.23% | NEW | |
| 48 | IMVT | Immunovant INC | Stock-Other | 0.22% | +0.22% | NEW | |
| 49 | ENTA | Enanta Pharmaceuticals INC | Stock-Other | 0.21% | — | +3.59% | |
| 50 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.21% | — | — |
Performance for Q3 2026
+16.7%
Performance Last 4 Quarters
+25.9%
Based on 5 months of available history
Based on 72% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 172 | $17.5B | 100 | |
| 2025-12-31 | 151 | $21.2B | 0 | |
| 2025-09-30 | 144 | $24.4B | 100 | |
| 2025-06-30 | 141 | $23.2B | 0 | |
| 2025-03-31 | 135 | $17.9B | 0 | |
| 2024-12-31 | 138 | $19.7B | 0 | |
| 2024-09-30 | 153 | $20.4B | 0 | |
| 2024-06-30 | 157 | $21.2B | 0 | |
| 2024-03-31 | 167 | $22.1B | 0 | |
| 2023-12-31 | 150 | $20.1B | 0 | |
| 2023-09-30 | 159 | $20.0B | 0 | |
| 2023-06-30 | 165 | $17.9B | 0 | |
| 2023-03-31 | 187 | $17.7B | 0 | |
| 2022-12-31 | 232 | $15.3B | 0 | |
| 2022-09-30 | 298 | $16.8B | 0 | |
| 2022-06-30 | 297 | $16.3B | 0 | |
| 2022-03-31 | 307 | $18.8B | 0 | |
| 2021-12-31 | 290 | $18.7B | 0 | |
| 2021-09-30 | 293 | $19.7B | 0 | |
| 2021-06-30 | 288 | $22.5B | 0 | |
| 2021-03-31 | 229 | $18.0B | 0 | |
| 2020-12-31 | 131 | $15.4B | 0 | |
| 2020-09-30 | 119 | $14.1B | 0 | |
| 2020-06-30 | 117 | $12.2B | 0 | |
| 2020-03-31 | 98 | $11.4B | 0 | |
| 2019-12-31 | 113 | $12.5B | 0 | |
| 2019-09-30 | 89 | $9.8B | 0 | |
| 2019-06-30 | 98 | $12.1B | 0 | |
| 2019-03-31 | 92 | $12.4B | 0 | |
| 2018-12-31 | 94 | $12.2B | 0 | |
| 2018-09-30 | 102 | $16.9B | 0 | |
| 2018-06-30 | 95 | $16.2B | 46 | |
| 2018-03-31 | 86 | $14.4B | 43 | |
| 2017-12-31 | 81 | $12.3B | 58 | |
| 2017-09-30 | 85 | $11.3B | 50 | |
| 2017-06-30 | 81 | $9.6B | 60 | |
| 2017-03-31 | 72 | $9.1B | 73 | |
| 2016-12-31 | 71 | $8.7B | 76 | |
| 2016-09-30 | 67 | $6.8B | 61 | |
| 2016-06-30 | 64 | $7.3B | 69 | |
| 2016-03-31 | 75 | $10.5B | 61 | |
| 2015-12-31 | 67 | $11.2B | 86 | |
| 2015-09-30 | 82 | $7.6B | 90 | |
| 2015-06-30 | 95 | $7.4B | 85 | 1441060225490A3148887 |
| 2015-03-31 | 94 | $6.8B | 88 | 1716933225490A387264S |
| 2014-12-31 | 88 | $7.3B | 76 | 10184902G2554F325490A |
| 2014-09-30 | 85 | $6.2B | 67 | 125490A2G2554F3786514 |
| 2014-06-30 | 98 | $6.9B | 66 | |
| 2014-03-31 | 88 | $5.1B | 67 | |
| 2013-12-31 | 79 | $4.8B | 68 | |
| 2013-09-30 | 77 | $4.9B | 71 | |
| 2013-06-30 | 82 | $5.2B | 0 |
Farallon Capital Management LLC's most significant position changes for 2026-03-31: New buy: Spdr S&p 500 ETF Tr; New buy: Revolution Medicines INC (RVMD); New buy: Amazon.com INC (AMZN); New buy: Microsoft CORP (MSFT); New buy: Aon plc (AON).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&p 500 ETF Tr | — | NEW | New buy |
| 2 | RVMD | Revolution Medicines INC | — | NEW | New buy |
| 3 | AMZN | Amazon.com INC | — | NEW | New buy |
| 4 | MSFT | Microsoft CORP | — | NEW | New buy |
| 5 | AON | Aon plc | — | NEW | New buy |
| 6 | BBIO | Bridgebio Pharma INC | — | NEW | New buy |
| 7 | ✓ | Invesco Exchange Traded Fd T | — | NEW | New buy |
| 8 | PTGX | Protagonist Therapeutics INC | — | NEW | New buy |
| 9 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 10 | NTRA | Natera INC | — | NEW | New buy |
| 11 | EXEL | Exelixis INC | — | NEW | New buy |
| 12 | AVGO | Broadcom INC | — | NEW | New buy |
| 13 | UNH | Unitedhealth Group INC | — | NEW | New buy |
| 14 | SNPS | Synopsys INC | — | NEW | New buy |
| 15 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 16 | TMO | Thermo Fisher Scientific INC | — | NEW | New buy |
| 17 | KKR | Kkr & Co INC | — | NEW | New buy |
| 18 | LNTH | Lantheus Holdings INC | — | NEW | New buy |
| 19 | WAB | Wabtec CORP | — | NEW | New buy |
| 20 | SCHW | Schwab (charles) CORP | — | NEW | New buy |
| 21 | LQDA | Liquidia CORP | — | NEW | New buy |
| 22 | CRNX | Crinetics Pharmaceuticals In | — | NEW | New buy |
| 23 | GOOG | Alphabet Inc-cl C | — | NEW | New buy |
| 24 | ROIV | Roivant Sciences Ltd. | — | NEW | New buy |
| 25 | V | Visa Inc-class A Shares | — | NEW | New buy |
| 26 | ARMK | Aramark | — | NEW | New buy |
| 27 | BEAM | Beam Therapeutics INC | — | NEW | New buy |
| 28 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 29 | DIS | Walt Disney Co/the | — | NEW | New buy |
| 30 | MA | Mastercard INC - A | — | NEW | New buy |
| 31 | MCK | Mckesson CORP | — | NEW | New buy |
| 32 | AGIO | Agios Pharmaceuticals INC | — | NEW | New buy |
| 33 | 260 | Centessa Pharmaceuticals-adr | — | NEW | New buy |
| 34 | TNGX | Tango Therapeutics INC | — | NEW | New buy |
| 35 | GRAL | Grail INC | — | NEW | New buy |
| 36 | TYRA | Tyra Biosciences INC | — | NEW | New buy |
| 37 | THC | Tenet Healthcare CORP | — | NEW | New buy |
| 38 | CAH | Cardinal Health INC | — | NEW | New buy |
| 39 | PCVX | Vaxcyte INC | — | NEW | New buy |
| 40 | DNTH | Dianthus Therapeutics INC | — | NEW | New buy |
| 41 | BTSG | Brightspring Health Services | — | NEW | New buy |
| 42 | TWST | Twist Bioscience CORP | — | NEW | New buy |
| 43 | BIDU | Baidu INC - Spon Adr | — | NEW | New buy |
| 44 | CGON | Cg Oncology INC | — | NEW | New buy |
| 45 | AZN | AstraZeneca PLC | — | NEW | New buy |
| 46 | VNET 2 10-01-27 | Vnet Group INC | — | NEW | New buy |
| 47 | MRK | Merck & Co. INC. | — | NEW | New buy |
| 48 | ACHC | Acadia Healthcare Co INC | — | NEW | New buy |
| 49 | WELL | Welltower INC | — | NEW | New buy |
| 50 | IMVT | Immunovant INC | — | NEW | New buy |